Charles Schwab’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $119M | Sell |
1,377,103
-8,776
| -0.6% | -$770K | 0.02% | 694 |
|
|
2026
Q1 | $125M | Buy |
1,385,879
+72,968
| +6% | +$6.7M | 0.02% | 615 |
|
|
2025
Q4 | $118M | Buy |
1,312,911
+28,801
| +2% | +$2.73M | 0.02% | 647 |
|
|
2025
Q3 | $126M | Buy |
1,284,110
+28,795
| +2% | +$2.85M | 0.02% | 596 |
|
|
2025
Q2 | $114M | Buy |
1,255,315
+1,886
| +0.2% | +$182K | 0.02% | 615 |
|
|
2025
Q1 | $142M | Buy |
1,253,429
+48,764
| +4% | +$5.22M | 0.03% | 490 |
|
|
2024
Q4 | $127M | Sell |
1,204,665
-6,336
| -0.5% | -$680K | 0.02% | 542 |
|
|
2024
Q3 | $131M | Sell |
1,211,001
-13,561
| -1% | -$1.48M | 0.03% | 527 |
|
|
2024
Q2 | $133M | Sell |
1,224,562
-1,752
| -0.1% | -$207K | 0.03% | 516 |
|
|
2024
Q1 | $162M | Sell |
1,226,314
-84
| -0% | -$10.5K | 0.04% | 412 |
|
|
2023
Q4 | $149M | Buy |
1,226,398
+22,764
| +2% | +$2.54M | 0.04% | 402 |
|
|
2023
Q3 | $135M | Sell |
1,203,634
-29,850
| -2% | -$3.79M | 0.04% | 399 |
|
|
2023
Q2 | $180M | Sell |
1,233,484
-2,716
| -0.2% | -$369K | 0.05% | 327 |
|
|
2023
Q1 | $160M | Buy |
1,236,200
+11,064
| +0.9% | +$1.39M | 0.05% | 344 |
|
|
2022
Q4 | $156M | Buy |
1,225,136
+31,154
| +3% | +$3.62M | 0.05% | 335 |
|
|
2022
Q3 | $125M | Buy |
1,193,982
+105,660
| +10% | +$11.6M | 0.04% | 364 |
|
|
2022
Q2 | $114M | Buy |
1,088,322
+42,115
| +4% | +$5M | 0.04% | 401 |
|
|
2022
Q1 | $134M | Buy |
1,046,207
+25,609
| +3% | +$3.09M | 0.04% | 409 |
|
|
2021
Q4 | $126M | Buy |
1,020,598
+37,390
| +4% | +$4.89M | 0.04% | 441 |
|
|
2021
Q3 | $140M | Sell |
983,208
-73,819
| -7% | -$10.9M | 0.05% | 370 |
|
|
2021
Q2 | $165M | Buy |
1,057,027
+2,573
| +0.2% | +$417K | 0.05% | 315 |
|
|
2021
Q1 | $164M | Buy |
1,054,454
+26,672
| +3% | +$4.13M | 0.06% | 291 |
|
|
2020
Q4 | $154M | Sell |
1,027,782
-52,879
| -5% | -$7.47M | 0.06% | 289 |
|
|
2020
Q3 | $143M | Sell |
1,080,661
-11,796
| -1% | -$1.54M | 0.07% | 267 |
|
|
2020
Q2 | $127M | Buy |
1,092,457
+92,764
| +9% | +$10.7M | 0.06% | 283 |
|
|
2020
Q1 | $98.1M | Buy |
999,693
+35,045
| +4% | +$4.59M | 0.06% | 292 |
|
|
2019
Q4 | $140M | Buy |
964,648
+21,623
| +2% | +$2.98M | 0.08% | 243 |
|
|
2019
Q3 | $126M | Buy |
943,025
+29,045
| +3% | +$3.75M | 0.07% | 257 |
|
|
2019
Q2 | $104M | Buy |
913,980
+24,232
| +3% | +$2.84M | 0.06% | 287 |
|
|
2019
Q1 | $110M | Buy |
889,748
+32,229
| +4% | +$3.66M | 0.07% | 259 |
|
|
2018
Q4 | $86.4M | Buy |
857,519
+46,532
| +6% | +$5.23M | 0.07% | 268 |
|
|
2018
Q3 | $104M | Buy |
810,987
+44,992
| +6% | +$5.35M | 0.07% | 257 |
|
|
2018
Q2 | $82.9M | Sell |
765,995
-9,967
| -1% | -$1.08M | 0.06% | 309 |
|
|
2018
Q1 | $82.1M | Sell |
775,962
-26,373
| -3% | -$3.06M | 0.06% | 289 |
|
|
2017
Q4 | $94M | Buy |
802,335
+28,572
| +4% | +$3.23M | 0.07% | 254 |
|
|
2017
Q3 | $88M | Buy |
773,763
+84,052
| +12% | +$9.7M | 0.08% | 243 |
|
|
2017
Q2 | $86M | Buy |
689,711
+7,492
| +1% | +$888K | 0.08% | 245 |
|
|
2017
Q1 | $80.9M | Buy |
682,219
+39,776
| +6% | +$4.51M | 0.08% | 241 |
|
|
2016
Q4 | $64.4M | Buy |
642,443
+55,074
| +9% | +$5.9M | 0.07% | 276 |
|
|
2016
Q3 | $74.1M | Buy |
587,369
+52,967
| +10% | +$6.54M | 0.09% | 239 |
|
|
2016
Q2 | $62.5M | Buy |
534,402
+20,653
| +4% | +$2.34M | 0.08% | 260 |
|
|
2016
Q1 | $53.2M | Buy |
513,749
+32,803
| +7% | +$3.17M | 0.07% | 286 |
|
|
2015
Q4 | $47.9M | Buy |
480,946
+25,895
| +6% | +$2.53M | 0.06% | 293 |
|
|
2015
Q3 | $41.5M | Buy |
455,051
+3,998
| +0.9% | +$401K | 0.06% | 300 |
|
|
2015
Q2 | $47.8M | Buy |
451,053
+4,922
| +1% | +$545K | 0.07% | 283 |
|
|
2015
Q1 | $50.9M | Buy |
446,131
+23,690
| +6% | +$2.7M | 0.07% | 270 |
|
|
2014
Q4 | $46.5M | Buy |
422,441
+14,861
| +4% | +$1.57M | 0.07% | 275 |
|
|
2014
Q3 | $39.8M | Buy |
407,580
+8,061
| +2% | +$793K | 0.07% | 281 |
|
|
2014
Q2 | $40.3M | Buy |
399,519
+15,789
| +4% | +$1.54M | 0.07% | 271 |
|
|
2014
Q1 | $35.2M | Buy |
383,730
+12,821
| +3% | +$1.18M | 0.06% | 293 |
|
|
2013
Q4 | $33.6M | Sell |
370,909
-29,328
| -7% | -$2.54M | 0.06% | 291 |
|
|
2013
Q3 | $32M | Sell |
400,237
-88,135
| -18% | -$6.94M | 0.07% | 286 |
|
|
2013
Q2 | $35.6M | Buy |
+488,372
| New | +$36.5M | 0.08% | 243 |
|
Other funds holding ZBH
Charles Schwab's ZBH Position: Q2 2026 in Review
Charles Schwab reduced its Zimmer Biomet (ZBH) stake by 0.63% in Q2 2026, selling an estimated $770K and leaving 1,377,103 shares worth $119M. The position accounts for 0.02% of the portfolio, ranked #694.
Charles Schwab first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $180M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Charles Schwab held 1,377,103 shares of Zimmer Biomet worth $119M as of Q2 2026.
- Charles Schwab sold 8,776 Zimmer Biomet shares in Q2 2026, an estimated $770K.
- Zimmer Biomet made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #694 holding.
- Charles Schwab first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Zimmer Biomet position peaked at $180M in Q2 2023.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.